Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD
Authors:
- 5 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 23 (8) , 1382-1393
Abstract
Background. Although anti–tumor necrosis factor (TNF) agents are effective in patients with inflammatory bowel disease (IBD), many patients either do not responKeywords
Funding Information
- F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
- NIH (P01 DK046763, U01 DK062413)
- European Union
- The Leona M and Harry B Helmsley Charitable Trust
This publication has 66 references indexed in Scilit:
- Rac2-Deficiency Leads to Exacerbated and Protracted Colitis in Response to Citrobacter rodentium InfectionPLOS ONE, 2013
- STRING v9.1: protein-protein interaction networks, with increased coverage and integrationNucleic Acids Research, 2012
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Genome wide association (GWA) predictors of anti-TNFα therapeutic responsiveness in pediatric inflammatory bowel diseaseInflammatory Bowel Diseases, 2010
- Infliximab, Azathioprine, or Combination Therapy for Crohn's DiseaseNew England Journal of Medicine, 2010
- Reactome knowledgebase of human biological pathways and processesNucleic Acids Research, 2008
- PID: the Pathway Interaction DatabaseNucleic Acids Research, 2008
- Biological Roles for the NOX Family NADPH OxidasesJournal of Biological Chemistry, 2008
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Human protein reference database as a discovery resource for proteomicsNucleic Acids Research, 2004